Antiendothelial cell antibodies in inflammatory myopathies: Distribution among clinical and serologic groups and association with interstitial lung disease

Journal of Rheumatology

Volumn 27, Issue 1, 2000, Pages 161-164

  D'Cruz, David ^a,d   Keser, Gokhan ^a   Khamashta, Munther A ^a   Direskeneli, Haner ^a   Targoff, Ira N ^b   Miller, Frederick ^c   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Antiendothelial cell antibodies; Antisynthetase antibodies interstitial lung disease; Idiopathic inflammatory myopathies

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TRANSFER RNA;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; IDIOPATHIC DISEASE; INFLAMMATORY DISEASE; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYOPATHY; MYOSITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY;

ADULT; AUTOANTIBODIES; ENDOTHELIUM; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; SENSITIVITY AND SPECIFICITY;

EID: 0033978035     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Emslie-Smith A, Engel AG. Microvascular changes in early and advanced dermatomyositis. A quantitative study. Ann Neurol 1990;27:343-56.
2. Estruch R, Grau JM, Fernandez-Sola J, Casademont J, Munforte R, Urbano-Marquez A. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 1992;23:885-95.
3. Engel AG, Arahata K, Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytoloxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986;17:704-21.
4. Miller FW, Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies. JAMA 1993;270:1846-9.
5. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogenous patient groups. Medicine (Baltimore) 1991;70:360-74.
6. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990;33:1361-70.
7. Cervera R. Ramirez G. Fernandez-Sola J. et al. Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease. BMJ 1991;302:880-1.
8. Grau JM, Miró O, Pedrol E. et al. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol 1996;23:1921-6.
9. Lakhanpal S. Lie JT, Conn DL. Martin WJ. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;40:23-9.
10. D'Cruz DP, Houssiau FA, Ramirez G. et al. Antiendothelial cell antibodies in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991;85:254-61.
11. Brown RA, Swanson Beck J, Medical statistics on microcomputers. London: British Medical Association; 1990:11-9.
12. Tan EM, Pearson CM, Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 1972;15:23-8.
13. Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971;9:753-60.
14. van der Zee JM, Siegert CEH, De Vreede TA, Daha MR, Breedveld FC. Characterisation of anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1991;84:238-44.
15. van der Zee JM, Miltenburg AM, Siegert CE, Daha MR, Breedveld FC. Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1 stimulated endothelium. Int Arch Allergy Immunol 1994;104:131-6.
16. Del Papa N, Meroni PL, Barcellini W, et al. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992;63:267-74.